Literature DB >> 16136652

DNA methylation and human disease.

Keith D Robertson1.   

Abstract

DNA methylation is a crucial epigenetic modification of the genome that is involved in regulating many cellular processes. These include embryonic development, transcription, chromatin structure, X chromosome inactivation, genomic imprinting and chromosome stability. Consistent with these important roles, a growing number of human diseases have been found to be associated with aberrant DNA methylation. The study of these diseases has provided new and fundamental insights into the roles that DNA methylation and other epigenetic modifications have in development and normal cellular homeostasis.

Entities:  

Mesh:

Year:  2005        PMID: 16136652     DOI: 10.1038/nrg1655

Source DB:  PubMed          Journal:  Nat Rev Genet        ISSN: 1471-0056            Impact factor:   53.242


  975 in total

1.  High-fat diet leads to a decreased methylation of the Mc4r gene in the obese BFMI and the lean B6 mouse lines.

Authors:  S Widiker; S Karst; A Wagener; G A Brockmann
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

Review 2.  Epigenetic regulation and measurement of epigenetic changes.

Authors:  Kimberly E Stephens; Christine A Miaskowski; Jon D Levine; Clive R Pullinger; Bradley E Aouizerat
Journal:  Biol Res Nurs       Date:  2012-06-03       Impact factor: 2.522

3.  Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease.

Authors:  Lei Yu; Lori B Chibnik; Gyan P Srivastava; Nathalie Pochet; Jingyun Yang; Jishu Xu; James Kozubek; Nikolaus Obholzer; Sue E Leurgans; Julie A Schneider; Alexander Meissner; Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

4.  Measurement of genome-wide DNA methylation predicts survival benefits from chemotherapy in non-small cell lung cancer.

Authors:  Min-Li Mo; Jie Ma; Zhao Chen; Bing Wei; Hui Li; Yong Zhou; Huaiyin Shi; Bhairavi Tolani; Joy Q Jin; Hsin-Hui Tseng; Dong Shen; Yi Zhan; Jun Li; David M Jablons; Rong-Qing Zhang; Yongjun Guo; Biao He; Hai-Meng Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-04       Impact factor: 4.553

5.  Prostaglandin E2 Reverses the Effects of DNA Methyltransferase Inhibitor and TGFB1 on the Conversion of Naive T Cells to iTregs.

Authors:  Mehmet Sahin; Emel Sahin
Journal:  Transfus Med Hemother       Date:  2019-09-19       Impact factor: 3.747

6.  Maternal gametic transmission of translocations or inversions of human chromosome 11p15.5 results in regional DNA hypermethylation and downregulation of CDKN1C expression.

Authors:  Adam C Smith; Masako Suzuki; Reid Thompson; Sanaa Choufani; Michael J Higgins; Idy W Chiu; Jeremy A Squire; John M Greally; Rosanna Weksberg
Journal:  Genomics       Date:  2011-11-03       Impact factor: 5.736

7.  DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.

Authors:  Stela S Palii; Beth O Van Emburgh; Umesh T Sankpal; Kevin D Brown; Keith D Robertson
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

8.  Sex-specific hippocampal 5-hydroxymethylcytosine is disrupted in response to acute stress.

Authors:  Ligia A Papale; Sisi Li; Andy Madrid; Qi Zhang; Li Chen; Pankaj Chopra; Peng Jin; Sündüz Keleş; Reid S Alisch
Journal:  Neurobiol Dis       Date:  2016-08-26       Impact factor: 5.996

9.  Detection and Mapping of DNA Methylation with 2D Material Nanopores.

Authors:  Hu Qiu; Aditya Sarathy; Klaus Schulten; Jean-Pierre Leburton
Journal:  NPJ 2D Mater Appl       Date:  2017-04-11

10.  DNA methylation represses IFN-gamma-induced and signal transducer and activator of transcription 1-mediated IFN regulatory factor 8 activation in colon carcinoma cells.

Authors:  Jon M McGough; Dafeng Yang; Shuang Huang; David Georgi; Stephen M Hewitt; Christoph Röcken; Marc Tänzer; Matthias P A Ebert; Kebin Liu
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.